Showing results (641-650 of 4,512) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|February 19, 2020
Prognostic impact of preoperative immunonutritional status in rectal mucinous adenocarcinomaYanwu Sun, Zhekun Huang, Huiming Lin, et al.
Future Oncology (London, England)|February 27, 2020
Gut microbiota and cancer immunotherapy: prognostic and therapeutic implicationsDeniz Can Guven, Burak Yasin Aktas, Cem Simsek, et al.
Future Oncology (London, England)|February 11, 2020
Low preoperative serum ALB level is independently associated with poor overall survival in endometrial cancer patientsJia Lei, Yue Wang, Xiangqian Guo, et al.
Future Oncology (London, England)|November 6, 2019
Treatment characteristics for nonmetastatic castration-resistant prostate cancer in the United States, Europe and JapanRuchitbhai Shah, Marc Botteman, Reginald Waldeck
Future Oncology (London, England)|February 6, 2020
Treatment patterns in non-small-cell lung cancer in USA: results of the CancerMPact Survey 2018David Robinson, Stephanie Hawthorne, Linda Zhao, et al.
Future Oncology (London, England)|January 10, 2020
First-line trifluridine/tipiracil plus bevacizumab for unresectable metastatic colorectal cancer: SOLSTICE study designThierry André, Mark Saunders, Akira Kanehisa, et al.
Future Oncology (London, England)|January 10, 2020
Delayed use of eribulin in a heavily pretreated liposarcoma patient, previously misdiagnosed as leiomyosarcomaFederica Martorana, Paolo Vigneri, Livia Manzella, et al.
Future Oncology (London, England)|January 10, 2020
Response to eribulin in a patient with metastatic uterine leiomyosarcoma: a case reportSandra Aliberti, Sara Miano, Francesco Tolomeo, et al.
Future Oncology (London, England)|March 5, 2020
Larotrectinib, a selective tropomyosin receptor kinase inhibitor for adult and pediatric tropomyosin receptor kinase fusion cancersAnna F Farago, George D Demetri
Future Oncology (London, England)|January 23, 2020
Identifying patterns of failure and secondary primary malignancies in HPV-related oropharyngeal squamous cell carcinomasRyan Holstead, Rehana Rasul, Anne Golden, et al.
Pageof 452